Navigation Links
Interleukin Genetics to Chair Expert Panel Discussion on Use of Biomarkers in Drug Development at BIO Convention
Date:5/12/2009

Senior Experts from Nordic Bioscience, Biomarker Strategies and Pharma on Panel

WALTHAM, Mass., May 12 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (NYSE Amex: ILI) announced today that CEO Lewis H. Bender will moderate and co-present a panel discussion titled "Integrating Genetic Markers in Drug Development: How Personalized Medicine is Evolving Predictive Treatment" at the BIO International Convention, being held May 18-21, 2009 in Atlanta, GA. The panel discussion will be held Tuesday, May 19 from 8-9:30 a.m. in Room B304 of the Georgia World Congress Center (Building B).

Co-presenting alongside Interleukin Genetics will be Reid Leonard, Ph.D., Executive Director of Licensing and External Research, Merck Research Laboratories; Douglas Clark, M.D., Chief Scientific Officer, Biomarker Strategies; and Morten Karsdal, Ph.D., Vice President, Research and Development, Nordic Bioscience.

"Biomarkers can be effectively used to improve the success rate in drug development. Genetic biomarkers that can be used to screen and select for patients in clinical trials to improve likelihood of trial success and improve safety for patients can save costs and reduce the time needed to bring new compounds to market," said Mr. Bender. "We're pleased that the Biotechnology Industry Organization recognizes the importance of this topic by selecting this panel to present."

The panel will provide expert insights, respectively, on integration and commercialization issues for biomarkers in drug development and how simple genetic tests and other types of biomarkers are poised to help curb an increasing innovation gap especially with regard to complex diseases. Discussion will focus on:

  • The various different biomarker types that can be used effectively for drug development

  • '/>"/>

SOURCE Interleukin Genetics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Interleukin Genetics Announces Conference Call to Discuss First Quarter 2009 Results
2. Interleukin Genetics Grants LABEC Pharma a License for Sales and Distribution of Its Heart Health Genetic Test
3. Interleukin Genetics Receives NYSE Amex Staff Determination, Requests Oral Hearing Before the Listing Qualifications Panel
4. Interleukin Genetics Announces Conference Call to Discuss Fourth Quarter 2008 Results
5. Interleukin Genetics to Present at G-2 Reports Molecular Diagnostic Conference
6. Interleukin Genetics Submits Plan to Regain Compliance with Continued Listing Standards
7. Interleukin Genetics to Present Data Highlighting Link Between Inflammatory Gene Variations and Less Effective Weightloss
8. Novel bioreactor enhances interleukin-12 production in genetically-modified tobacco plants
9. Interleukin Genetics Announces Conference Call and Webcast to Discuss Third Quarter 2008 Business Results
10. Interleukin Genetics to Present at Rodman & Renshaw 10th Annual Healthcare Conference
11. Interleukin-12 indicates survival prospects for melanoma patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... ... June 30, 2015 , ... New ... expedited through the use of new forms, according to attorneys handling Xarelto ... and the Short Form Complaint, “provide guidance” for plaintiffs’ attorneys in filing new ...
(Date:6/30/2015)... ... June 30, 2015 , ... When it comes to volunteering abroad, not many ... costs will be too high. However, there are affordable programs to be had such ... at minimal cost. One such volunteer named Uzma Aishah, a student at the International ...
(Date:6/30/2015)... ... 2015 , ... Bill Howe Plumbing, Inc. is one of ... Howe offers all employees ample opportunity for education and training in their field, ... local Plumbing-Heating-Cooling-Contractors of San Diego (PHCC-SD). The San Diego plumbing company ...
(Date:6/30/2015)... CT (PRWEB) , ... June 30, 2015 , ... ... on Wednesday, June 24, 2015 amidst bright skies and inspirational words. , ... the cherished processional walk from the Glenholme building to the school’s Center for ...
(Date:6/30/2015)... ... June 30, 2015 , ... Lecrae is quickly developing into one ... Rolling Stone and The New York Times to Billboard Magazine and Variety, among others. ... of the many reasons why so many people are taking notice. , “We are ...
Breaking Medicine News(10 mins):Health News:Xarelto Lawsuit News: New Xarelto Lawsuit Filings to Be Expedited 2Health News:Xarelto Lawsuit News: New Xarelto Lawsuit Filings to Be Expedited 3Health News:Volunteers Transform Themselves and Their Resumes with Medical Volunteer Placements Abroad 2Health News:Volunteers Transform Themselves and Their Resumes with Medical Volunteer Placements Abroad 3Health News:Two Local San Diego Plumbers from Bill Howe Plumbing, Inc. Graduate from PHCC Academy 2Health News:Two Local San Diego Plumbers from Bill Howe Plumbing, Inc. Graduate from PHCC Academy 3Health News:The Glenholme School Graduates Its Class of 2015 2Health News:The Glenholme School Graduates Its Class of 2015 3Health News:The Glenholme School Graduates Its Class of 2015 4Health News:Hands of Hope to Present Grammy Award-Winner Lecrae in Concert this August 2Health News:Hands of Hope to Present Grammy Award-Winner Lecrae in Concert this August 3
... Researchers have identified a new candidate tumor suppressor gene in ... in stool samples, according to a new study published online ... Institute . In the study, Manon van Engeland, Ph.D., ... in the Netherlands, and colleagues examined N-Myc downstream-regulated gene 4 ...
... Mich.---Some video games can make children kinder and more ... of new research published in the current (June 2009) ... a top-tier, peer-reviewed academic journal. The article presents ... countries with different age groups, and using different scientific ...
... for both healthcare providers and consumers , , ... Office of the National Coordinator for Health IT (ONCHIT) ... and in an effort to keep healthcare leaders informed, ... will host a webinar to provide an industry perspective ...
... IRVINE, Calif., June 17 HealthTronics, Inc. ("HealthTronics") (Nasdaq: ... ENDO ) announced today that HealthTronics has ... shares of Endocare common stock pursuant to their previously-announced ... terms and conditions of the exchange offer, Endocare stockholders ...
... program for delinquent kids showed surprise benefit , WEDNESDAY, ... a history of juvenile delinquency in specialized foster-care programs ... pregnant, researchers found. , Researchers directed 166 girls aged ... to receive treatment for criminal behavior to either specialized ...
... treated so babies aren,t infected, study finds , WEDNESDAY, ... to screen all pregnant women for group B streptococcal ... , Eighty-five percent of women in the United ... appropriate treatment. , "This paper highlights an important public ...
Cached Medicine News:Health News:Promising biomarker and candidate tumor suppressor gene identified for colorectal cancer 2Health News:Playing video games for better, not worse 2Health News:Playing video games for better, not worse 3Health News:Perot Systems Webinar: An Industry Perspective on HIT Policy Committee's Framework for 'Meaningful Use' 2Health News:Perot Systems Webinar: An Industry Perspective on HIT Policy Committee's Framework for 'Meaningful Use' 3Health News:HealthTronics, Inc. Commences Exchange Offer for Endocare, Inc. Shares 2Health News:HealthTronics, Inc. Commences Exchange Offer for Endocare, Inc. Shares 3Health News:Close Monitoring May Help Troubled Teen Girls Avoid Pregnancy 2Health News:Group B Strep Screening Guidelines Sparing Newborns 2Health News:Group B Strep Screening Guidelines Sparing Newborns 3
(Date:6/30/2015)... -- Pulse Light Clinic in London,s ... as part of their ongoing research into the condition. They ... their Rosacea. The survey participants were aged between 20 and ... women. The results revealed some rather surprising statistics: ... attempt to visit their GP for Rosacea treatment. ...
(Date:6/30/2015)... 30, 2015 First Choice Wellness Care recently ... Duality and is the only clinic in the greater ... removal treatments. The practice has recently expanded their services ... to showcase their focus in the procedure. They upgraded ... faster ink clearance, and superior service. "We,ve ...
(Date:6/30/2015)... 2015  Avanir Pharmaceuticals, Inc. today announced top-line ... treatment with NUEDEXTA ® was associated with ... affect (PBA) in patients with traumatic brain injury ... characterized by sudden and uncontrollable outbursts of laughing ... brain injury. PRISM II is a phase IV ...
Breaking Medicine Technology:84% of Rosacea Sufferers Say NHS Treatments Were "Ineffective" New Survey Reveals 284% of Rosacea Sufferers Say NHS Treatments Were "Ineffective" New Survey Reveals 3First Choice Wellness Care Becomes Tallahassee Leader In Tattoo Removal With Astanza Duality 2First Choice Wellness Care Becomes Tallahassee Leader In Tattoo Removal With Astanza Duality 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 2Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 4Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 5Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 6Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 7
... 2011 Fuisz ( www.fuisz.com ) today announced the ... Permitting Stage Door Access to On-Line Vendor Information"). ... "This patent covers a system that allows a customer ... a product supplier database through the on-line vendor,s system ...
... 15, 2011 Cardium Therapeutics (NYSE Amex: ... from the Russian Ministry of Health and Social Development ... Company,s Generx™ (alferminogene tadenovec, Ad5FGF-4) biologic product candidate.  Generx ... for the potential treatment of myocardial ischemia due to ...
Cached Medicine Technology:Generx DNA-Based Angiogenic Therapy Receives Russian Ministry of Health Clearance for Late-Stage Registration Clinical Study for Coronary Artery Disease 2Generx DNA-Based Angiogenic Therapy Receives Russian Ministry of Health Clearance for Late-Stage Registration Clinical Study for Coronary Artery Disease 3Generx DNA-Based Angiogenic Therapy Receives Russian Ministry of Health Clearance for Late-Stage Registration Clinical Study for Coronary Artery Disease 4Generx DNA-Based Angiogenic Therapy Receives Russian Ministry of Health Clearance for Late-Stage Registration Clinical Study for Coronary Artery Disease 5Generx DNA-Based Angiogenic Therapy Receives Russian Ministry of Health Clearance for Late-Stage Registration Clinical Study for Coronary Artery Disease 6Generx DNA-Based Angiogenic Therapy Receives Russian Ministry of Health Clearance for Late-Stage Registration Clinical Study for Coronary Artery Disease 7
... D-Type can combine a number of ... microplates on a simple to use ... is a multifunctional stand-alone device but ... robotic systems. Custom and standard add-on ...
Grab one and go, One of the smallest handheld oximeters available, Datex-Ohmeda s TuffSat is the ideal spot-check solution for hospital, home care, transport, and EMS. TuffSat comes fully loaded wi...
Smith & Nephew's CDS System is developed exclusively for discography., Developed exclusively for discography, it is the first system designed to measure true disc pressure and record real-time proce...
The Maxi-Therm® lite hyper-hypothermia water blankets from Cincinnati Sub-Zero take conductive warming and cooling therapy to a new, softer level. These blankets are soft, lightweight, and remai...
Medicine Products: